Methylcobalamin functions as a ready-to-use coenzyme form, eliminating the need for conversion by the body. The same applies to methyl folate. With approximately 44% of the population affected by the MTFHR gene mutation, it becomes challenging for their bodies to perform this conversion, potentially leading to nutrient deficiencies.
Selecting the appropriate form of supplements is essential, particularly if you're uncertain about falling into the 44% category affected by this gene mutation, where conversion is impaired.